The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 16, 2005
Filed:
Sep. 26, 2002
József Barkóczy, Budapest, HU;
András Egyed, Budapest, HU;
István Gacsályi, Budapest, HU;
László Hársing, Budapest, HU;
Hajnalka Kompagne, Budapest, HU;
Péter Kótay Nagy, Vác, HU;
György Lévay, Budakeszi, HU;
Csilla Leveleki, Budapest, HU;
Bernadett Martonné Markó, Budapest, HU;
Anikó Miklósné Kovács, Budapest, HU;
Éva Schmidt, Budapest, HU;
Gyula Simig, Budapest, HU;
Gábor Szénási, Budapest, HU;
János Wellmann, Budapest, HU;
József Barkóczy, Budapest, HU;
András Egyed, Budapest, HU;
István Gacsályi, Budapest, HU;
László Hársing, Budapest, HU;
Hajnalka Kompagne, Budapest, HU;
Péter Kótay Nagy, Vác, HU;
György Lévay, Budakeszi, HU;
Csilla Leveleki, Budapest, HU;
Bernadett Martonné Markó, Budapest, HU;
Anikó Miklósné Kovács, Budapest, HU;
Éva Schmidt, Budapest, HU;
Gyula Simig, Budapest, HU;
Gábor Szénási, Budapest, HU;
János Wellmann, Budapest, HU;
Egis Gyogyszergyar Rt., Budapest, HU;
Abstract
The invention relates to substituted alkylaminopyridazinone derivatives of the general Formula (I), (wherein Ris hydrogen or alkyl having 1-4 carbon atoms; one of X and Y stands for hydrogen or halogen and the other represents a group of the general Formula (II), Ris hydrogen or alkyl having 1-4 carbon atoms; n is 1, 2 or 3; Rstands for hydrogen, alkyl having 1-4 carbon atoms or aryl-(Calkyl); Z stands for oxygen; or Rand Z together with the groups placed between them form a piperazine ring; and Rstands for hydrogen, halogen, trifluoromethyl or alkoxy having 1-4 carbon atoms) and pharmaceutically acceptable acid addition salts thereof. The invention compounds are useful in the treatment of anxiolytic conditions and cognitive disorders.